Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 1–1 | Cite as

First batch of Japanese package insert revisions for 2019

News item
  • 71 Downloads

References

  1. 1.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Nusinersen sodium. Internet Document : [1 page], 10 Jan 2019. Available from: URL: http://www.pmda.go.jp/files/000227477.pdf
  2. 2.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Axitinib. Internet Document : [1 page], 10 Jan 2019. Available from: URL: http://www.pmda.go.jp/files/000227478.pdf
  3. 3.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Lenalidomide hydrate. Internet Document : [1 page], 10 Jan 2019. Available from: URL: http://www.pmda.go.jp/files/000227479.pdf
  4. 4.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Fluoroquinolones (oral and injectable dosage forms). Internet Document : [13 pages], 10 Jan 2019. Available from: URL: http://www.pmda.go.jp/files/000227480.pdf
  5. 5.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Asunaprevir, daclatasvir hydrochloride, daclatasvir hydrochloride/asunaprevir/beclabuvir hydrochloride. Internet Document : [2 pages], 10 Jan 2019. Available from: URL: http://www.pmda.go.jp/files/000227481.pdf

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations